Perrigo FDA Approved To Market Nicotine Gum

Armen Hareyan's picture
Advertisement

The Perrigo Company has received approval from FDA to market over-the-counter (OTC) Nicotine Polacrilex Gum USP, 2 mg (base) and 4 mg (base) (Orange, Coated).

Advertisement

The FDA has determined the product to be bioequivalent to the reference listed drug, GlaxoSmithKline's Nicorette Gum, 2 mg (base) and 4 mg (base), which is an aid to smoking cessation.

"This approval of orange-flavored, coated nicotine gum extends our leading store brand position. Our expanded range of smoking cessation products also includes coated mint-flavored gum, coated fruit-flavored gum, uncoated gum and lozenges," said Joseph C. Papa, Perrigo's Chairman and CEO.

The overall market for OTC nicotine gum and lozenge products is estimated at approximately $750 million annually at all retail outlets.

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.
Advertisement